Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Parents' Informed Consent (IC) obtained before any trial-related activities~* Obtained child's assent (when possible)~* Type 1 diabetes~* Treatment with insulin detemir and insulin aspart either in extemporaneous mixed or separate injections~* HbA1c (glycosylated haemoglobin A1c) lesser than or equal to 8.6%~Exclusion Criteria:~* History of alcoholism, drug abuse, or psychiatric disease or personality disorders likely to invalidate voluntary consent or to prevent good compliance with the trial protocol~* Mental incapacity, unwillingness or language barrier precluding adequate understanding or co-operation~* Anticipated change or new use in concomitant medication known to interfere with glucose metabolism, such as systemic corticotherapy more than 5 mg/day (prednisone)~* Any other condition that the Investigator (trial physician) feels would interfere with trial participation or evaluation of results

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Mixed injection (Type: EXPERIMENTAL): None
- Separate injection (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).